Anti-EGFR scFv fragment and Bispecific anti-c-Met/anti-EGFR antibodies comprising the same

摘要

Provided in an embodiment is polypeptide. Provided in another embodiment are one or more kind of a heavy chain complementarity determining region selected among a group consisting of CDR-H1,CDR-H2, and CDR-H3, one or more kind of a low chain complementarity determining region; or an anti-EGFR including the combination of the same or an antibody combined fragment of the same. Provided in an embodiment is polypeptide having a new sequence. The polypeptide can have a function of an anti-EGFR antibody as CDR.